53 related articles for article (PubMed ID: 28414026)
1. Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury.
Huang D; Wang C; Duan Y; Meng Q; Liu Z; Huo X; Sun H; Ma X; Liu K
Toxicol Appl Pharmacol; 2017 Jul; 326():15-24. PubMed ID: 28414026
[TBL] [Abstract][Full Text] [Related]
2. MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury.
Thomasova D; Ebrahim M; Fleckinger K; Li M; Molnar J; Popper B; Liapis H; Kotb AM; Siegerist F; Endlich N; Anders HJ
Cell Death Dis; 2016 Nov; 7(11):e2482. PubMed ID: 27882940
[TBL] [Abstract][Full Text] [Related]
3. Hazel Leaf Polyphenol Extract Alleviated Cisplatin-Induced Acute Kidney Injury by Reducing Ferroptosis through Inhibiting Hippo Signaling.
Sun M; Chang H; Jiang F; Zhang W; Yang Q; Wang X; Lv G; Lin H; Luo H; Lin Z; Wang Y
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675549
[TBL] [Abstract][Full Text] [Related]
4. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.
Molitoris BA; Dagher PC; Sandoval RM; Campos SB; Ashush H; Fridman E; Brafman A; Faerman A; Atkinson SJ; Thompson JD; Kalinski H; Skaliter R; Erlich S; Feinstein E
J Am Soc Nephrol; 2009 Aug; 20(8):1754-64. PubMed ID: 19470675
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media.
Michael A; Faga T; Pisani A; Riccio E; Bramanti P; Sabbatini M; Navarra M; Andreucci M
Biomed Res Int; 2014; 2014():249810. PubMed ID: 24745009
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targets of formononetin for treating prostate cancer at the single-cell level.
Li J; Huang Z; Wang P; Li R; Gao L; Lai KP
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38874510
[TBL] [Abstract][Full Text] [Related]
7. Formononetin attenuates kidney damage in type 2 diabetic rats.
Oza MJ; Kulkarni YA
Life Sci; 2019 Feb; 219():109-121. PubMed ID: 30641085
[TBL] [Abstract][Full Text] [Related]
8. Formononetin Upregulates Nrf2/HO-1 Signaling and Prevents Oxidative Stress, Inflammation, and Kidney Injury in Methotrexate-Induced Rats.
Aladaileh SH; Hussein OE; Abukhalil MH; Saghir SAM; Bin-Jumah M; Alfwuaires MA; Germoush MO; Almaiman AA; Mahmoud AM
Antioxidants (Basel); 2019 Sep; 8(10):. PubMed ID: 31561418
[TBL] [Abstract][Full Text] [Related]
9. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
10. Formononetin: A Review of Its Anticancer Potentials and Mechanisms.
Tay KC; Tan LT; Chan CK; Hong SL; Chan KG; Yap WH; Pusparajah P; Lee LH; Goh BH
Front Pharmacol; 2019; 10():820. PubMed ID: 31402861
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic effects of Formononetin in an inflammatory pain mouse model.
Wang XS; Guan SY; Liu A; Yue J; Hu LN; Zhang K; Yang LK; Lu L; Tian Z; Zhao MG; Liu SB
Mol Brain; 2019 Apr; 12(1):36. PubMed ID: 30961625
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays.
Hu W; Wu X; Tang J; Zhao G; Xiao N; Zhang L; Li S
J Cell Mol Med; 2019 May; 23(5):3505-3511. PubMed ID: 30873755
[TBL] [Abstract][Full Text] [Related]
13. Astragali Radix and its compound formononetin ameliorate diesel particulate matter-induced skin barrier disruption by regulation of keratinocyte proliferation and apoptosis.
Nguyen LTH; Nguyen UT; Kim YH; Shin HM; Yang IJ
J Ethnopharmacol; 2019 Jan; 228():132-141. PubMed ID: 30243826
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Intracellular ROS Accumulation by Formononetin Attenuates Cisplatin-Mediated Apoptosis in LLC-PK1 Cells.
Lee H; Lee D; Kang KS; Song JH; Choi YK
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534504
[TBL] [Abstract][Full Text] [Related]
15. The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure.
Fu Y; Xiang Y; Wang Y; Liu Z; Yang D; Zha J; Tang C; Cai J; Chen G; Dong Z
Theranostics; 2023; 13(9):2757-2773. PubMed ID: 37284446
[No Abstract] [Full Text] [Related]
16. Cisplatin nephrotoxicity: new insights and therapeutic implications.
Tang C; Livingston MJ; Safirstein R; Dong Z
Nat Rev Nephrol; 2023 Jan; 19(1):53-72. PubMed ID: 36229672
[TBL] [Abstract][Full Text] [Related]
17. Clonidine ameliorates cisplatin-induced nephrotoxicity: impact on OCT2 and p38 MAPK pathway.
Fawzy MH; Khodeer DM; Elsayed NM; Ahmed YM; Saeed NM
J Pharm Pharmacol; 2022 Aug; 74(8):1180-1192. PubMed ID: 35704284
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.
McSweeney KR; Gadanec LK; Qaradakhi T; Ali BA; Zulli A; Apostolopoulos V
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805488
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.
Holditch SJ; Brown CN; Lombardi AM; Nguyen KN; Edelstein CL
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226747
[TBL] [Abstract][Full Text] [Related]
20. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis.
Chen X; Wei W; Li Y; Huang J; Ci X
Chem Biol Interact; 2019 Aug; 308():269-278. PubMed ID: 31153982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
